Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer

M Bauer,1 J Bryce,2 P Hadji11University of Marburg, Marburg, Germany; 2National Cancer Institute, Naples, ItalyAbstract: Postmenopausal women have an increased risk of osteopenia and osteoporosis due to loss of the bone-protective effects of estrogen. Disease-related processes may also contribute to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bauer M, Bryce J, Hadji P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/5ee8db3a3ee946ffae223c84f4fcb28c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!